Target intelligence / Profile preview

Yersinia pestis F1 capsule antigen (F1 antigen)

Target
F1 antigen
Molecular classification
Bacterial surface protein, Capsular protein, Chaperone-usher system protein
01

Overview

The Yersinia pestis F1 capsule antigen is a major surface component of the bacterium responsible for the plague. Encoded by the caf1 gene on the pFra plasmid, this protein is expressed and assembled into a large, gel-like capsule when the pathogen is exposed to mammalian body temperatures (37°C). Its primary biological role is to act as a potent antiphagocytic factor, preventing host immune cells such as macrophages and neutrophils from engulfing the bacteria, thereby facilitating systemic spread and high mortality. In the context of therapeutics and diagnostics, the F1 antigen is the most critical target for plague prevention and identification. It serves as the primary component of modern recombinant subunit vaccines (often paired with the V antigen) and is the basis for rapid diagnostic tests used in the field to detect Y. pestis in clinical samples. While highly conserved, the existence of naturally occurring or engineered F1-negative strains remains a significant challenge for vaccine efficacy and biodefense strategies.

Other names
Fraction 1 antigenCaf1 proteinCapsular antigen F1Yersinia pestis capsular proteinF1 protein
02

Mechanism of action

Induction of protective neutralizing antibodies that facilitate opsonophagocytosis and prevent bacterial dissemination.

03

Biological functions

Antiphagocytic activityBacterial virulenceImmune evasionProtein polymerization
04

Disease associations

InfectionPlague (Bubonic, Septicemic, Pneumonic)
05

Safety considerations

Emergence of F1-negative virulent strainsLimited protection against F1-deficient Yersinia pestisPotential for low immunogenicity in subunit forms without adjuvants
06

Interacting drugs

rF1-V subunit vaccine

2 more in the full profile.

07

Biomarkers

F1 antigen (detected via RDT or ELISA)Anti-F1 IgG antibodiesAnti-F1 IgM antibodies

Beyond the preview

Go deeper on Yersinia pestis F1 capsule antigen (F1 antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yersinia pestis F1 capsule antigen (F1 antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call